Conference · Stevenage, United Kingdom
Antibody Drug Conjugates
Biotechnology · Biology · Biochemistry
Key numbers
- Editions on record
- 1first in 2013
About Antibody Drug Conjugates
This event is part of the 2013 Euroscicon BioTherapeutics Week, to find out more see www.biotherapeutics2013.com
Who Should Attend
Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research
Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students
People working in •Antibody Development
•Antibody Discovery
•Antibody Engineering
•Formulation Development
•Biologics
•Monoclonal antibody operations
•Immunoassay development
•Protein Engineering
•Translational Research
•Discovery Chemistry
•Molecular Medicine
•Molecular Discovery Research
•Molecular Biology and Chemistry
•Regulatory Affairs
•Business Development
•Genomics
Speakers include
Mahendra Deonarain, Imperial College, London
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2013 | 14 May 2013 | The Stevenage Bioscience Catalyst Stevenage, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Antibody Drug Conjugates?
The next dates haven't been confirmed. The last edition we have on record was 14 May 2013.
Where is it held?
The last edition we have was at The Stevenage Bioscience Catalyst, Stevenage, United Kingdom.